Javascript must be enabled to continue!
Analysis of Oncological Outcomes After Robotic Liver Resection for Intrahepatic Cholangiocarcinoma
View through CrossRef
Background
Concerns regarding minimally invasive liver resection of intrahepatic cholangiocarcinoma (IHCC) include inadequate resection margins and inferior long-term overall survival (OS) when compared to an “open” approach. Limited data exists to address these issues. We aimed to compare perioperative variables, tumor distance to margin, and long-term outcomes after IHCC resection based on surgical approach (robotic vs open) in our hepatobiliary center to address these concerns.
Methods
With IRB approval, 34 patients who underwent robotic or open hepatectomy for IHCC were prospectively followed. Patients were stratified by tumor distance to resection margin (≤1 mm, 1.1-9.9 mm, ≥10 mm) for illustrative purposes and by approach (robotic vs open). Where appropriate, regression analysis and cox model of proportional hazards were utilized. Survival was stratified by margin distance and approach utilizing Kaplan-Meier curves. Data are presented as median (mean ± SD).
Results
Patients undergoing robotic vs open hepatectomy had similar demographics. Patients undergoing the robotic approach had significantly lower estimated blood loss (EBL). Tumor distance to margin between the two approaches were similar ( P = .428). Median OS between the two approaches was similar in patients of any margin distance. In the subgroup analysis by margin distance, the robotic approach yielded less EBL for patients in the 1.1-9.9 mm and ≥10 mm margin groups, and a shorter ICU length of stay for patients with ≥10 mm margin.
Discussion
Similar margins were attained via either approach, translating into oncological non-inferiority of robotic IHCC resection. Robotic approach for the treatment of IHCC should be considered an alternative to an open approach.
Title: Analysis of Oncological Outcomes After Robotic Liver Resection for Intrahepatic Cholangiocarcinoma
Description:
Background
Concerns regarding minimally invasive liver resection of intrahepatic cholangiocarcinoma (IHCC) include inadequate resection margins and inferior long-term overall survival (OS) when compared to an “open” approach.
Limited data exists to address these issues.
We aimed to compare perioperative variables, tumor distance to margin, and long-term outcomes after IHCC resection based on surgical approach (robotic vs open) in our hepatobiliary center to address these concerns.
Methods
With IRB approval, 34 patients who underwent robotic or open hepatectomy for IHCC were prospectively followed.
Patients were stratified by tumor distance to resection margin (≤1 mm, 1.
1-9.
9 mm, ≥10 mm) for illustrative purposes and by approach (robotic vs open).
Where appropriate, regression analysis and cox model of proportional hazards were utilized.
Survival was stratified by margin distance and approach utilizing Kaplan-Meier curves.
Data are presented as median (mean ± SD).
Results
Patients undergoing robotic vs open hepatectomy had similar demographics.
Patients undergoing the robotic approach had significantly lower estimated blood loss (EBL).
Tumor distance to margin between the two approaches were similar ( P = .
428).
Median OS between the two approaches was similar in patients of any margin distance.
In the subgroup analysis by margin distance, the robotic approach yielded less EBL for patients in the 1.
1-9.
9 mm and ≥10 mm margin groups, and a shorter ICU length of stay for patients with ≥10 mm margin.
Discussion
Similar margins were attained via either approach, translating into oncological non-inferiority of robotic IHCC resection.
Robotic approach for the treatment of IHCC should be considered an alternative to an open approach.
Related Results
[RETRACTED] Bridport Health Reviews - Powerfully Detoxifies The Liver, Lose Liver Fat And Improve Gut Health! v1
[RETRACTED] Bridport Health Reviews - Powerfully Detoxifies The Liver, Lose Liver Fat And Improve Gut Health! v1
[RETRACTED]Product Name - Bridport Health Ingredients - Milk Thistle, Beetroot, Artichoke Extract & More. Category - Liver Support Supplement Main Benefits - Helps Protect The ...
[RETRACTED] Bridport Health Liver Support Does It Really Work v1
[RETRACTED] Bridport Health Liver Support Does It Really Work v1
[RETRACTED]Depiction • Where to Get Bottle Online –Click Here • Item Name -Bridport Health Liver • Aftereffects - No Major Side Effects • Classification - Health • Accessibility -O...
c‐erbB‐2 and c‐Met expression relates to cholangiocarcinogenesis and progression of intrahepatic cholangiocarcinoma
c‐erbB‐2 and c‐Met expression relates to cholangiocarcinogenesis and progression of intrahepatic cholangiocarcinoma
c‐erbB‐2 and c‐Met expression relates to cholangiocarcinogenesis and progression of intrahepatic cholangiocarcinoma Aims: The c‐erbB‐2 and c‐Met proto‐oncogenes are important for ...
Regional versus Extended Lymph Node Dissection for Intrahepatic Cholangiocarcinoma: a randomized controlled trial protocol
Regional versus Extended Lymph Node Dissection for Intrahepatic Cholangiocarcinoma: a randomized controlled trial protocol
ABSTRACT
Introduction
The mainstay treatment for intrahepatic cholangiocarcinoma is surgical resection, the impact of lymph nod...
Robotic resection of hilar cholangiocarcinoma: a single institution experience
Robotic resection of hilar cholangiocarcinoma: a single institution experience
Aim: Hilar cholangiocarcinoma is an aggressive malignancy with a poor prognosis, for which only surgical resection offers potential cure. Because of its complex location in the por...
Multimodal treatment of an advanced intrahepatic cholangiocarcinoma and its recurrence – a case report
Multimodal treatment of an advanced intrahepatic cholangiocarcinoma and its recurrence – a case report
Introduction: Intrahepatic cholangiocarcinoma (ICC) is rare and often diagnosed in an advanced stage. Neoadjuvant therapy is not established and data on its value are in palliative...
Mass spectrometry-based analysis of formalin-fixed, paraffin-embedded distal cholangiocarcinoma identifies stromal thrombospondin-2 as a potential prognostic marker
Mass spectrometry-based analysis of formalin-fixed, paraffin-embedded distal cholangiocarcinoma identifies stromal thrombospondin-2 as a potential prognostic marker
Abstract
Background
Distal cholangiocarcinoma is an aggressive malignancy with a dismal prognosis. Diagnostic and prognostic biomarkers for distal c...
Risk Factors for Anorectal Dysfunction After Interspincteric Resection in Patients With Low Rectal Cancer
Risk Factors for Anorectal Dysfunction After Interspincteric Resection in Patients With Low Rectal Cancer
Purpose: The objective of this study was to explore the risk factors for anorectal dysfunction after intersphincteric resection in patients with low rectal cancer.Methods: A total ...

